$659.00 – $2,299.00
Sutent is indicated for the treatment of unresectable or metastatic, well-differentiated NPV with disease progression in adults.Sutent is indicated for the treatment of advanced and/or metastatic renal cell carcinoma, as well as after ineffective treatment with imatinib mesylate due to resistance or intolerance.
Active ingredient: Sunitinib
Prescription medicine
| Дозировка | 12 Mg, 25 Mg, 50 Mg |
|---|
